DLX6 and neoplasm: Furthermore, the treatment with Wnt/β-catenin signaling activator, LiCl, attenuated the inhibitory effects of DLX6-AS1 on tumor cell growth, proliferation, invasion and migration in T24 cells (Fig. 5c, d).